Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Leblanc

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Journal of Neurological Surgery. Part B, Skull Base|January 18, 2014
Communicating hydrocephalus and vestibular schwannomas: etiology, treatment, and long-term follow-upQasim Al Hinai, Anthony Zeitouni, Denis Sirhan, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 30, 2021
Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline ConsortiumRichard LeBlanc, Debra J Bergstrom, Julie Côté, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trialKhalil Sultanem, Horacio Patrocinio, Christine Lambert, et al.
The Oncologist|May 1, 2013
Efficacy and safety of busulfan-based conditioning regimens for multiple myelomaDonna Reece, Kevin Song, Richard LeBlanc, et al.
Psychosomatic Medicine|January 28, 2005
Psychologic distress in postmyocardial infarction patients who have returned to workChantal Brisson, Richard Leblanc, Renée Bourbonnais, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2023
First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline ConsortiumJulie Côté, Rami Kotb, Debra J Bergstrom, et al.
Blood Cancer Journal|January 6, 2022
Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myelomaJean-Sébastien Claveau, Sophie Savary Bélanger, Imran Ahmad, et al.
Journal of Neurosurgery|October 22, 2021
No woman alone: Dorothy Russell's legacy to neurosurgeryJubran H Jubran, Lena Mary Houlihan, Ann J Staudinger Knoll, et al.
Journal of Neuro-Oncology|July 5, 2008
Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant gliomaTejas Sankar, Zografos Caramanos, Rachid Assina, et al.
Cancer Research|September 6, 2005
Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cellsMikael Altun, Paul J Galardy, Reshma Shringarpure, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Journal of Neurological Surgery. Part B, Skull Base|January 18, 2014
Communicating hydrocephalus and vestibular schwannomas: etiology, treatment, and long-term follow-upQasim Al Hinai, Anthony Zeitouni, Denis Sirhan, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 30, 2021
Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline ConsortiumRichard LeBlanc, Debra J Bergstrom, Julie Côté, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trialKhalil Sultanem, Horacio Patrocinio, Christine Lambert, et al.
The Oncologist|May 1, 2013
Efficacy and safety of busulfan-based conditioning regimens for multiple myelomaDonna Reece, Kevin Song, Richard LeBlanc, et al.
Psychosomatic Medicine|January 28, 2005
Psychologic distress in postmyocardial infarction patients who have returned to workChantal Brisson, Richard Leblanc, Renée Bourbonnais, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2023
First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline ConsortiumJulie Côté, Rami Kotb, Debra J Bergstrom, et al.
Blood Cancer Journal|January 6, 2022
Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myelomaJean-Sébastien Claveau, Sophie Savary Bélanger, Imran Ahmad, et al.
Journal of Neurosurgery|October 22, 2021
No woman alone: Dorothy Russell's legacy to neurosurgeryJubran H Jubran, Lena Mary Houlihan, Ann J Staudinger Knoll, et al.
Journal of Neuro-Oncology|July 5, 2008
Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant gliomaTejas Sankar, Zografos Caramanos, Rachid Assina, et al.
Cancer Research|September 6, 2005
Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cellsMikael Altun, Paul J Galardy, Reshma Shringarpure, et al.
Pageof 12